The layoffs at AbbVie’s Irvine, California, location will take effect on July 20, according to a recent WARN notice. More: AbbVie plots 85 summer layoffs tied to Allergan unit in California Source: fierce
read moreLess than a month after an FDA advisory committee recommended rejection of AstraZeneca’s novel cancer drug, Europe’s CHMP has blessed Etcamah with a positive opinion. The EMA also has signed off on Novo Nordisk’s Wegovy pill. More: Europe's CHMP gives
read moreAbbVie’s 85 layoffs are tied to its Allergan Aesthetics headquarters in California, while Novartis is cutting more staff at its U.S. HQ in New Jersey. More: Novartis, AbbVie plan summer layoffs on opposite coasts Source: fierce
read moreA three-way battle among TROP2 ADCs in first-line triple-negative breast cancer is forming as AstraZeneca and Daiichi Sankyo’s Datroway became the first to cross the FDA’s finish line. More: AstraZeneca, Daiichi beat Gilead to first-line TNBC with FDA nod for
read moreAbbVie and GSK have surged up the rankings of the pharma companies with the best reputations among U.K. patient groups, contributing to turnover at the top of the leaderboards. More: AbbVie, GSK race up patient reputation leaderboard in the UK
read more© 1994 - 2026 B.M. Pharmaceuticals